جدول الترويج Soleno Therapeutics, Inc.
الجدول الزمني المتقدم
رسم بياني بسيط
عن الشركة Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.| IPO date | 2014-11-13 |
|---|---|
| ISIN | US8342033094 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://soleno.life |
| Цена ао | 48.97 |
| تغير السعر يوميا: | +6.83% (67.39) |
|---|---|
| تغير السعر في الأسبوع: | +46.59% (49.11) |
| تغير السعر شهريا: | +59.62% (45.1) |
| تغير السعر خلال 3 أشهر: | +60.62% (44.82) |
| تغير السعر على مدى ستة أشهر: | +42.58% (50.49) |
| تغير السعر سنويا: | +68.2% (42.8) |
| تغير السعر على مدى 3 سنوات: | +24 444.83% (0.2933) |
| تغير السعر على مدى 5 سنوات: | +2 498.92% (2.77) |
| تغير الأسعار منذ بداية العام: | +60.62% (44.82) |
|
|
الاستهانة
|
كفاءة
|
|||||||||||||||||||||||||||||||||||||
توزيعات الأرباح
|
واجب
|
دافع النمو
|
|||||||||||||||||||||||||||||||||||||
| المؤسسات | مقدار | يشارك, % |
|---|---|---|
| Vivo Capital, LLC | 8418093 | 25.93 |
| Nantahala Capital Management, LLC | 5712702 | 17.6 |
| Perceptive Advisors LLC | 3074542 | 9.47 |
| Carlyle Group Inc. | 2857804 | 8.8 |
| Janus Henderson Group PLC | 2523897 | 7.78 |
| Adage Capital Partners GP L.L.C. | 1826814 | 5.63 |
| Vestal Point Capital, LP | 1300000 | 4 |
| Vanguard Group Inc | 969622 | 2.99 |
| Balyasny Asset Management LLC | 926876 | 2.86 |
| Avoro Capital Advisors LLC | 785000 | 2.42 |
| ETF | يشارك, % | الربحية لهذا العام, % | توزيعات الأرباح, % |
|---|---|---|---|
iShares Russell 2000 Growth ETF
|
0.08818 | 38.04 | 0.6026 |
| iShares ESG Aware MSCI USA Small-Cap ETF | 0.04862 | 18.09 | 1.49366 |
| iShares Morningstar Small-Cap Growth ETF | 0.04077 | 587.89 | 0.72598 |
| iShares Morningstar Small-Cap Growth ETF | 0.04077 | 33.63 | 0.72598 |
| iShares Morningstar Small-Cap ETF | 0.02055 | 391.25 | 1.60498 |
| iShares Morningstar Small-Cap ETF | 0.02055 | 30.1 | 1.60498 |
| iShares Russell 3000 ETF | 0.00204 | 24.83 | 1.43482 |
| 0.04 | 160.55 | 1.17 |
| مشرف | مسمى وظيفي | قسط | سنة الميلاد |
|---|---|---|---|
| Dr. Anish Bhatnagar M.D. | President, CEO, COO & Director | 1.06M | 1970 (55 سنين) |
| Mr. James H. MacKaness | Chief Financial Officer | 640k | 1964 (61 سنة) |
| Dr. Neil M. Cowen M.B.A., Ph.D. | Senior Vice President of Drug Development | N/A | |
| Ms. Kristen Yen M.S. | Senior Vice President of Clinical Operations | 317.19k | 1969 (56 سنين) |
| Ms. Meredith Manning M.B.A. | Chief Commercial Officer | N/A | 1972 (53 سنة) |
| Ms. Patricia C. Hirano M.P.H. | Senior Vice President of Regulatory Affairs | 493k | 1966 (59 سنين) |
| Ms. Lauren Budesheim | Vice President of People | N/A | |
| Dr. Michael Huang M.D. | Senior Vice President of Clinical Development | N/A | 1974 (51 سنة) |
| Dr. Raymond W. Urbanski M.D., Ph.D. | Chief Development Officer | 1959 (66 سنين) |
عنوان: United States, Redwood City. CA, 203 Redwood Shores Parkway - مفتوحة في خرائط جوجل, فتح خرائط ياندكس
موقع إلكتروني: https://soleno.life
موقع إلكتروني: https://soleno.life
